Entera Bio Ltd. (NASDAQ: ENTX) ('Entera” or the 'Company”), a leader in the development of oral peptides, today announced that an additional presentation highlighting the clinical study design for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results